Cargando…

Lipoproteins act as vehicles for lipid antigen delivery and activation of invariant natural killer T cells

Invariant natural killer T (iNKT) cells act at the interface between lipid metabolism and immunity because of their restriction to lipid antigens presented on CD1d by antigen-presenting cells (APCs). How foreign lipid antigens are delivered to APCs remains elusive. Since lipoproteins routinely bind...

Descripción completa

Detalles Bibliográficos
Autores principales: Engelen, Suzanne E., Ververs, Francesca A., Markovska, Angela, Lagerholm, B. Christoffer, Kraaijenhof, Jordan M., Yousif, Laura I.E., Zurke, Yasemin-Xiomara, Gulersonmez, Can M.C., Kooijman, Sander, Goddard, Michael, van Eijkeren, Robert J., Jervis, Peter J., Besra, Gurdyal S., Haitjema, Saskia, Asselbergs, Folkert W., Kalkhoven, Eric, Ploegh, Hidde L., Boes, Marianne, Cerundolo, Vincenzo, Hovingh, G.K., Salio, Mariolina, Stigter, Edwin C.A., Rensen, Patrick C.N., Monaco, Claudia, Schipper, Henk S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243825/
https://www.ncbi.nlm.nih.gov/pubmed/36976644
http://dx.doi.org/10.1172/jci.insight.158089
_version_ 1785054507228463104
author Engelen, Suzanne E.
Ververs, Francesca A.
Markovska, Angela
Lagerholm, B. Christoffer
Kraaijenhof, Jordan M.
Yousif, Laura I.E.
Zurke, Yasemin-Xiomara
Gulersonmez, Can M.C.
Kooijman, Sander
Goddard, Michael
van Eijkeren, Robert J.
Jervis, Peter J.
Besra, Gurdyal S.
Haitjema, Saskia
Asselbergs, Folkert W.
Kalkhoven, Eric
Ploegh, Hidde L.
Boes, Marianne
Cerundolo, Vincenzo
Hovingh, G.K.
Salio, Mariolina
Stigter, Edwin C.A.
Rensen, Patrick C.N.
Monaco, Claudia
Schipper, Henk S.
author_facet Engelen, Suzanne E.
Ververs, Francesca A.
Markovska, Angela
Lagerholm, B. Christoffer
Kraaijenhof, Jordan M.
Yousif, Laura I.E.
Zurke, Yasemin-Xiomara
Gulersonmez, Can M.C.
Kooijman, Sander
Goddard, Michael
van Eijkeren, Robert J.
Jervis, Peter J.
Besra, Gurdyal S.
Haitjema, Saskia
Asselbergs, Folkert W.
Kalkhoven, Eric
Ploegh, Hidde L.
Boes, Marianne
Cerundolo, Vincenzo
Hovingh, G.K.
Salio, Mariolina
Stigter, Edwin C.A.
Rensen, Patrick C.N.
Monaco, Claudia
Schipper, Henk S.
author_sort Engelen, Suzanne E.
collection PubMed
description Invariant natural killer T (iNKT) cells act at the interface between lipid metabolism and immunity because of their restriction to lipid antigens presented on CD1d by antigen-presenting cells (APCs). How foreign lipid antigens are delivered to APCs remains elusive. Since lipoproteins routinely bind glycosylceramides structurally similar to lipid antigens, we hypothesized that circulating lipoproteins form complexes with foreign lipid antigens. In this study, we used 2-color fluorescence correlation spectroscopy to show, for the first time to our knowledge, stable complex formation of lipid antigens α-galactosylceramide (αGalCer), isoglobotrihexosylceramide, and OCH, a sphingosine-truncated analog of αGalCer, with VLDL and/or LDL in vitro and in vivo. We demonstrate LDL receptor–mediated (LDLR-mediated) uptake of lipoprotein-αGalCer complexes by APCs, leading to potent complex-mediated activation of iNKT cells in vitro and in vivo. Finally, LDLR-mutant PBMCs of patients with familial hypercholesterolemia showed impaired activation and proliferation of iNKT cells upon stimulation, underscoring the relevance of lipoproteins as a lipid antigen delivery system in humans. Taken together, circulating lipoproteins form complexes with lipid antigens to facilitate their transport and uptake by APCs, leading to enhanced iNKT cell activation. This study thereby reveals a potentially novel mechanism of lipid antigen delivery to APCs and provides further insight into the immunological capacities of circulating lipoproteins.
format Online
Article
Text
id pubmed-10243825
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Society for Clinical Investigation
record_format MEDLINE/PubMed
spelling pubmed-102438252023-06-07 Lipoproteins act as vehicles for lipid antigen delivery and activation of invariant natural killer T cells Engelen, Suzanne E. Ververs, Francesca A. Markovska, Angela Lagerholm, B. Christoffer Kraaijenhof, Jordan M. Yousif, Laura I.E. Zurke, Yasemin-Xiomara Gulersonmez, Can M.C. Kooijman, Sander Goddard, Michael van Eijkeren, Robert J. Jervis, Peter J. Besra, Gurdyal S. Haitjema, Saskia Asselbergs, Folkert W. Kalkhoven, Eric Ploegh, Hidde L. Boes, Marianne Cerundolo, Vincenzo Hovingh, G.K. Salio, Mariolina Stigter, Edwin C.A. Rensen, Patrick C.N. Monaco, Claudia Schipper, Henk S. JCI Insight Research Article Invariant natural killer T (iNKT) cells act at the interface between lipid metabolism and immunity because of their restriction to lipid antigens presented on CD1d by antigen-presenting cells (APCs). How foreign lipid antigens are delivered to APCs remains elusive. Since lipoproteins routinely bind glycosylceramides structurally similar to lipid antigens, we hypothesized that circulating lipoproteins form complexes with foreign lipid antigens. In this study, we used 2-color fluorescence correlation spectroscopy to show, for the first time to our knowledge, stable complex formation of lipid antigens α-galactosylceramide (αGalCer), isoglobotrihexosylceramide, and OCH, a sphingosine-truncated analog of αGalCer, with VLDL and/or LDL in vitro and in vivo. We demonstrate LDL receptor–mediated (LDLR-mediated) uptake of lipoprotein-αGalCer complexes by APCs, leading to potent complex-mediated activation of iNKT cells in vitro and in vivo. Finally, LDLR-mutant PBMCs of patients with familial hypercholesterolemia showed impaired activation and proliferation of iNKT cells upon stimulation, underscoring the relevance of lipoproteins as a lipid antigen delivery system in humans. Taken together, circulating lipoproteins form complexes with lipid antigens to facilitate their transport and uptake by APCs, leading to enhanced iNKT cell activation. This study thereby reveals a potentially novel mechanism of lipid antigen delivery to APCs and provides further insight into the immunological capacities of circulating lipoproteins. American Society for Clinical Investigation 2023-05-08 /pmc/articles/PMC10243825/ /pubmed/36976644 http://dx.doi.org/10.1172/jci.insight.158089 Text en © 2023 Engelen et al. https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Engelen, Suzanne E.
Ververs, Francesca A.
Markovska, Angela
Lagerholm, B. Christoffer
Kraaijenhof, Jordan M.
Yousif, Laura I.E.
Zurke, Yasemin-Xiomara
Gulersonmez, Can M.C.
Kooijman, Sander
Goddard, Michael
van Eijkeren, Robert J.
Jervis, Peter J.
Besra, Gurdyal S.
Haitjema, Saskia
Asselbergs, Folkert W.
Kalkhoven, Eric
Ploegh, Hidde L.
Boes, Marianne
Cerundolo, Vincenzo
Hovingh, G.K.
Salio, Mariolina
Stigter, Edwin C.A.
Rensen, Patrick C.N.
Monaco, Claudia
Schipper, Henk S.
Lipoproteins act as vehicles for lipid antigen delivery and activation of invariant natural killer T cells
title Lipoproteins act as vehicles for lipid antigen delivery and activation of invariant natural killer T cells
title_full Lipoproteins act as vehicles for lipid antigen delivery and activation of invariant natural killer T cells
title_fullStr Lipoproteins act as vehicles for lipid antigen delivery and activation of invariant natural killer T cells
title_full_unstemmed Lipoproteins act as vehicles for lipid antigen delivery and activation of invariant natural killer T cells
title_short Lipoproteins act as vehicles for lipid antigen delivery and activation of invariant natural killer T cells
title_sort lipoproteins act as vehicles for lipid antigen delivery and activation of invariant natural killer t cells
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243825/
https://www.ncbi.nlm.nih.gov/pubmed/36976644
http://dx.doi.org/10.1172/jci.insight.158089
work_keys_str_mv AT engelensuzannee lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells
AT verversfrancescaa lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells
AT markovskaangela lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells
AT lagerholmbchristoffer lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells
AT kraaijenhofjordanm lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells
AT yousiflauraie lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells
AT zurkeyaseminxiomara lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells
AT gulersonmezcanmc lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells
AT kooijmansander lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells
AT goddardmichael lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells
AT vaneijkerenrobertj lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells
AT jervispeterj lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells
AT besragurdyals lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells
AT haitjemasaskia lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells
AT asselbergsfolkertw lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells
AT kalkhoveneric lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells
AT ploeghhiddel lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells
AT boesmarianne lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells
AT cerundolovincenzo lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells
AT hovinghgk lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells
AT saliomariolina lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells
AT stigteredwinca lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells
AT rensenpatrickcn lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells
AT monacoclaudia lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells
AT schipperhenks lipoproteinsactasvehiclesforlipidantigendeliveryandactivationofinvariantnaturalkillertcells